Abstract:Diagnostic approaches capable of ultrasensitive pathogen detection from low-volume clinical samples, running without any sophisticated instrument and laboratory setup, are easily field-deployable, inexpensive, and rapid, and are considered ideal for monitoring disease progression and surveillance. However, standard pathogen detection methods, including culture and microscopic observation, antibody-based serologic tests, and primarily polymerase chain reaction (PCR)-oriented nucleic acid screening techniques, have shortcomings that limit their widespread use in responding to outbreaks and regular diagnosis, especially in remote resource-limited settings (RLSs). Recently, clustered regularly interspaced short palindromic repeats (CRISPR)-based programmable technology has emerged to challenge the unmet criteria of conventional methods. It consists of CRISPR-associated proteins (Cas) capable of targeting virtually any specific RNA or DNA genome based on the guide RNA (gRNA) sequence. Furthermore, the discovery of programmable trans-cleavage Cas proteins like Cas12a and Cas13 that can collaterally damage reporter-containing single-stranded DNA or RNA upon formation of target Cas-gRNA complex has strengthened this technology with enhanced sensitivity. Current advances, including automated multiplexing, ultrasensitive single nucleotide polymorphism (SNP)-based screening, inexpensive paper-based lateral flow readouts, and ease of use in remote global settings, have attracted the scientific community to introduce this technology in nucleic-acid-based precise detection of bacterial and viral pathogens at the point of care (POC). This review highlights CRISPR-Cas-based molecular technologies in diagnosing several tropical diseases, namely malaria, zika, chikungunya, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV-AIDS), tuberculosis (TB), and rabies.

Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease

CRISPR-Based Programmable Nucleic Acid-Binding Protein Technology Can Specifically Detect Fatal Tropical Disease-Causing Pathogens

Point‐of‐Care Pathogen Detection with CRISPR‐based Programmable Nucleic Acid Binding Proteins

CRISPR-Cas systems: From gene scissors to programmable biosensors

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-based biosensors for pathogenic biosafety

[Application of CRISPR/Cas-based Biosensors for Detecting Nucleic Acid of Pathogens].

Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing

CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

Application of CRISPR/Cas Technology in Biological Nano‐Analysis

CRISPR-based biosensors for human health: A novel strategy to Detect emerging infectious diseases

Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection

Pathogen Detection Strategy Based on CRISPR

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application

Towards Point of Care CRISPR-Based Diagnostics: from Method to Device

Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies

CRISPR-based nucleic acid diagnostics for pathogens

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid